US FDA approves Novo Nordisk's Wegovy for lowering heart risks
Wegovy, also chemically known as semaglutide, belongs to a class of drugs called GLP-1 agonists. Read more at straitstimes.com.
Source: straitstimes.com
Chad Weldy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chad Weldy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chad Weldy Today - Breaking & Trending Today
US Obesity Docs Expect Zepbound to Show Heart Benefit
Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
Source: medscape.com
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
Some leading U.S. obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy as they belong...
Source: marketscreener.com
Ozempic maker says its Wegovy drug can cut risk of serious heart problems - National
Ozempic maker Novo Nordisk says the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone
Source: globalnews.ca
Wegovy's heart benefits due to more than weight loss, Novo says
Early data from trial showed it reduced incidence of heart attack, stroke, death from heart disease
Source: dunyanews.tv